Oct 8, 2020 7:45 am EDT Castle Biosciences Announces Expanded Medicare Coverage for DecisionDx-Melanoma in Cutaneous Melanoma
Oct 6, 2020 7:00 am EDT Castle Biosciences to Present Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
Aug 26, 2020 5:00 pm EDT Castle Biosciences to Hold Webcast Highlighting Commercial Launch of DecisionDx-SCC
Aug 5, 2020 7:00 am EDT Castle Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference
Jul 27, 2020 7:00 am EDT Castle Biosciences to Release Second Quarter 2020 Financial Results and Host Conference Call on Monday, August 10, 2020
Jul 15, 2020 8:42 am EDT Castle Biosciences Announces Publication of Clinical Utility, Long-Term Outcomes Data and Meta-Analysis for DecisionDx-UM for Patients with Uveal Melanoma
